Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
12,834
Total Claims
$1.2M
Drug Cost
1,004
Beneficiaries
$1,239
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-95%
Opioid rate vs peers
0.1% vs 2.2% avg
-12%
Cost per patient vs peers
$1,239 vs $1,411 avg
-6%
Brand preference vs peers
10.0% vs 10.6% avg
Opioid Prescribing
0.1%
Opioid Rate
15
Opioid Claims
$309
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,272 claims · $966K
Generic: 11,466 claims · $273K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 146 | $184K |
| Sitagliptin Phosphate | 88 | $123K |
| Semaglutide | 76 | $100K |
| Dulaglutide | 56 | $92K |
| Insulin Glargine,hum.Rec.Anlog | 60 | $45K |
| Dapagliflozin Propanediol | 23 | $37K |
| Rivaroxaban | 27 | $35K |
| Insulin Detemir | 28 | $30K |
| Budesonide/Formoterol Fumarate | 33 | $28K |
| Empagliflozin | 14 | $22K |
| Atorvastatin Calcium | 931 | $14K |
| Sacubitril/Valsartan | 19 | $13K |
| Gabapentin | 397 | $13K |
| Linaclotide | 12 | $12K |
| Insulin Aspart | 11 | $11K |
Prescribing Profile
Patient Profile
75
Avg Age
54%
Female
1.37
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data